What: The New York Times examines whether early cancers that rarely spread—such as DCIS—should be renamed to ease the psychological burden on patients.
Key line: “The name is ‘a relic from prior categorization schemes’…”
Source: New York Times.
A retrospective study found that preconception use of GLP-1 medications was associated with reduced risks of several adverse pregnancy outcomes.
A federal judge has paused planned NIH funding cuts, halting a proposed $4 billion reduction from research grants.
Vox examines strategies that might let Trump maintain a moderate image on abortion while enforcing restrictions.
A study finds that higher white blood cell counts in postmenopausal women may signal severe COVID-19.
Women voice frustrations over intrusive social media ads during perimenopause.
New techniques in managing maternal blood pressure are emerging.
A study reveals that from 2001 to 2020, early-onset breast cancer rates among women ages 25–39 varied significantly by region in the United States.
Profiles reveal that women in states with strict abortion bans are avoiding pregnancy for fear of inadequate health care.
A small randomized‐control trial found semaglutide cut drinking by 40% in people with alcohol use disorder.
Amid administrative chaos, the NIH acting director assured that key research projects would proceed.
The abrupt cancellation of NIH meetings may hinder critical medical research.
A New York physician faces indictment in Louisiana for prescribing abortion pills.
A marijuana business trade publication reports that some producers are eyeing cannabis-based treatments for women’s health issues.
Cannabis producers are exploring new treatment areas in women’s health.
Cosmo UK explores the phenomenon dubbed ‘post‐birth control syndrome’ despite its unofficial status.
RFK Jr. demonstrated uncertainty over Medicare fundamentals during his nomination hearing.
A study underscores that preventing preeclampsia is key to reducing serious postpartum complications.
The debate over rebranding early-stage cancers like DCIS aims to reduce patient anxiety.
A new survey reveals nearly one in four women under 50 consider health influencers as reliable as healthcare providers.
New York introduces a shield law to protect doctors who prescribe abortion medications.